Amplia Therapeutics Ltd
OTC:INNMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amplia Therapeutics Ltd
OTC:INNMF
|
AU |
|
M
|
Merck KGaA
F:MRK
|
DE |
|
Straumann Holding AG
F:QS51
|
CH |
|
Goodfellow Inc
F:O3Z
|
CA |
|
B
|
Bank of Communications Co Ltd
XMUN:C4C
|
CN |
Wall St Price Targets
INNMF Price Targets Summary
Amplia Therapeutics Ltd
According to Wall Street analysts, the average 1-year price target for
INNMF is 0.308 USD with a low forecast of 0.305 USD and a high forecast of 0.317 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INNMF's stock price target?
Price Target
0.308
USD
According to Wall Street analysts, the average 1-year price target for
INNMF is 0.308 USD with a low forecast of 0.305 USD and a high forecast of 0.317 USD.
What is the Revenue forecast for Amplia Therapeutics Ltd?
Projected CAGR
39%
Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 39%.